Global cardiac resynchronization therapy (crt) devices 2012-2018

www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
CARDIAC RESYNCHRONIZATION
THERAPY (CRT) DEVICES
GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2012-2018
PRICE: US$3250
NO. OF PAGES: 500
TABLES/CHARTS: 130
REPORT CODE: ARMMR128N.1
PUBLICATION: JUNE 2014

For more information on this report publication, please reach us at:
sales@axisresearchmind.com 2
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES
SEGMENTATION - By TYPE
 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
 CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES -
GLOBAL MARKET WATCH, 2012-2018
Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by
2016. The North America accounts for nearly 39% (2015) of the global value while Europe
claims approximately 32% (2018). Asia-Pacific is the fastest growing region with a CAGR of
12.8% driving a market value of US$590 million by 2016. On a global scale, projections for
Cardiac Resynchronization Therapy Defibrillator (CRT-D) market value indicate US$1.6 billion
by 2016 leaving the rest of the market to the Cardiac
Resynchronization Pacemakers (CRT-P).
Healthcare Industry division has been witnessing a
drastic change regarding the new innovation and technology which in terms are applied in
improving from sector to sector since the past 3-5 years. Cardiovascular industry growth
continues to increase with the presence of multiple technologies such as advanced material
and software which is featured in most of the devices. International companies tends to
innovate, develop new products and to enhance the existing features in cardiovascular devices.
GLOBAL CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES -
MARKET SHARE BY TYPE - 2015-%
“Getting the Most from Our Research
Analysis”

REPORT FOCUS
The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Global Trends,
Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular
devices with a perceptive attempt to disclose the near-future growth prospects. An in-
depth analysis on a geographic basis provides strategic business intelligence for
healthcare sector investments. The study reveals profitable investment strategies for
market start-ups, pharmaceutical/biotechnology companies, laboratories,
Contract/Clinical/Commercial Research Organizations (CROs), government/academic
organizations, consulting firms, database buyers and many more in preferred locations.
The report focuses on the current market trends, estimates and forecasts for the
period 2012-2018. More than 727 market players are identified in cardiovascular
devices industry out of which 122 key
companies that project improved market
activities in the near future are profiled. The
report consists of 130 data charts describing
the market shares, sales forecasts and
growth prospects. Moreover, key strategic activities in the market including
mergers/acquisitions, collaborations/partnerships, product launches/developments
are discussed which gives a deep insight into the growth perspectives of the market.
The market growth rate in the major economies such as the U.S., Japan, China etc.
are estimated individually.
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases & published research reports are also used for estimates.
KEY COMPANIES PROFILED
ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD.,
ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN
HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK
GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE
HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP
INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY
ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO
HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC.,
MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL
TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL
B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more…
“Learn High Potential Market Dynamics
for Strategic Business Planning”

GEOGRAPHIC COVERAGE
The region-wise distribution of the market consists of North America, Europe, Asia-
Pacific, Latin America and Rest of World with 19 countries, analyzed individually as
follows:
NORTH AMERICA USA & CANADA
EUROPE
GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA,
BELGIUM & REST OF EUROPE
ASIA-PACIFIC
JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA
& REST OF ASIA-PACIFIC
LATIN AMERICA BRAZIL, ARGENTINA & REST OF LATIN AMERICA
REST OF WORLD SOUTH AFRICA, MIDDLE EAST & REST OF REST OF WORLD
TO PURCHASE THIS REPORT, FOLLOW BELOW LINK:
Cardiac Resynchronization Therapy (CRT) Devices - Global
Trends, Estimates and Forecasts, 2012-2018

Global cardiac resynchronization therapy (crt) devices 2012-2018

Recommended

Recommended

More Related Content

Recently uploaded

Recently uploaded (20)

Featured

Featured (20)

Global cardiac resynchronization therapy (crt) devices 2012-2018